Oncology Med, Inc., to Merge with Haz Holdings, Inc.: The Company to Focus on the Full- and Mid- Service Hotel Industry.

SEATTLE -- Oncology Med, Inc. (OTC:ONCM) ("Oncology Med" or the "Company"), today announced that it has entered into an agreement to merge a wholly-owned subsidiary of the Company into Haz Holdings, Inc., a Delaware corporation ("Haz Holdings"), and rename the Company, "Haz Holdings, Inc." The agreement provides that all of the shares of common stock of Haz Holdings will be exchanged for not less than 80% of Oncology Med's outstanding common stock at the closing of this merger transaction. The closing of the agreement is conditioned upon the completion of customary due diligence.

Haz Holdings owns and manages three mid-scale, full-service hotels in the United States and Canada, under the brand names "Hotel Marquis & Suites" and "Marquis Inn & Suites." Its existing portfolio, the 174-room Hotel Marquis and Suites Intercontinental Airport hotel in Houston, Texas, the 203-room Hotel Marquis Airport in San Antonio, Texas, and the Marquis Inn & Suites, a 30-room economy hotel with 70 recreational vehicle units in Edmonton, Alberta, Canada.

Haz Holdings' five year business plan is to increase its hotel ownership portfolio while concurrently franchising hotels under its brand names. Near term strategy is to acquire properties at below replacement value and leverage its holdings toward further expansion. Karim Bhanji, CEO of Haz Holdings Inc., elaborated, "We intend to primarily focus on the expansion of Haz Holdings' operations and real estate portfolio in terms of both hotel ownership and franchises."

Management for Haz Holdings estimates its hotel portfolio current market value of $16 million dollars. Haz Holdings estimated 2006 year revenue of approximately $4 million dollars.

Additionally Haz Holdings wholly-owns four subsidiary businesses: Mortgage and Financial Institute, LLC, an early stage mortgage broker in commercial and residential lending in Washington and Alaska, Nationwide Hotel Management, LLC, a hotel management company, KB Realty Group International, LLC, a commercial and residential real estate sales company, and Evergreen Sound Construction, LLC, a commercial and residential development company.

Steve Careaga, CEO of Oncology Med, stated, "We are excited to have reached this agreement and to bring this opportunity to the Company's shareholders."

The Company also announced that, based on due diligence of the Company and GAK Acquisition Corp. ("GAK") pursuant to the prior merger agreement between the Company and GAK, dated March 17, 2006, under which the Company changed its name from "Nannaco, Inc.," to "Oncology Med, Inc." (the "GAK Merger"), the Company and GAK mutually terminated the GAK Merger.

More information about Haz Holdings, Inc. can be found at http://www.hazholdings.com.

About Oncology Med, Inc.

Oncology Med, f/k/a, Nannaco, Inc., previously provided surface cleaning, surface protection, surface restoration and other services to commercial and industrial businesses, as well as to owners of historical buildings. The company has subsequently sought to improve its financial position through the acquisition of, or merger with, companies capable of providing the best value to its shareholders.

NOTE: This press release may contain "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) the company's ability to manage it current merger transaction and commencement of operations (2) the company's limited operating history; (3) the company's ability to pay down existing debt; (4) the company's ability to secure necessary financing; (5) potential litigation by shareholders and/or former or current advisors against the company; (6) the company's ability to comply with federal, state and local government regulations and/or unforeseen changes in federal or and government regulations; and (7) the risks inherent in the investigation and consummation of the acquisition of a new business opportunity or other factors over which we have little or no control.